Skip to main content
Compliance & Ethics

Bristol-Myers Squibb conducts business with, and maintains a culture of, ethics and integrity across our worldwide organization. We require all our employees, in addition to contractors, consultants, vendors and individuals who do business with Bristol-Myers Squibb, to know and adhere to our high standards of ethics and integrity.

In our mission to discover, develop and deliver innovative medicines that help patients prevail over serious diseases, we support a clean and healthy environment and subscribe to policies and practices that merit the trust and confidence of our society.

Quick Links

Third Parties|Select Corporate Policies and Practices|Required State Declarations

Our Employees

Each of our employees is required to complete training on our Standards of Business Conduct and Ethics biannually, and to certify that they have read, understand, will comply with, and are not aware of any violations of the Standards. Timely completion of this training is a condition of employment. Our Standards address a broad range of topics relating to ethics and global business practices.

Bristol-Myers Squibb recognizes that Third Parties have an important role in its success. We strive to conduct business only with Third Parties who share our commitment to the Standards of Business Conduct and Ethics for Third Parties (3P Standards). We encourage Third Parties to adopt and apply the 3P Standards, and to have processes and/or systems in place to support operating in compliance with all applicable laws, regulations, guidelines and industry codes. Specific requirements for adherence to the 3P Standards are included in contracts with third parties.

Select Corporate Policies and Practices

The following Corporate Policies include those referenced in the Standards of Business Conduct and Ethics as well as others that may be of interest to our customers and shareholders:

Policy Number Policy Title
BMS-CP-001 Non-Discrimination and Anti-Harassment
BMS-CP-002 Substance Abuse Prevention
BMS-CP-003 Threats and Acts of Violence in the Workplace
BMS-CP-004 Environment, Health & Safety
BMS-CP-005 BMS Records Management
BMS-CP-006 Computer System Usage and Information Asset Protection
BMS-CP-007 Securities Trading
BMS-CP-008 Receiving Honoraria for Presentations
BMS-CP-009 Conflicts of Interest
BMS-CP-010 Disclosure of Material Information
BMS-CP-011 Fair Competition
BMS-CP-012 Trademarks and Copyrights
BMS-CP-013 Purchasing
BMS-CP-014 Quality
BMS-CP-016 Privacy
BMS-CP-017 Management of Direct Customer Product Inventory Levels
BMS-CP-027 Reporting Potential Compliance Incidents*
BMS-CP-030 Animal Care and Use
BMS-CP-034 Anti-Bribery
BMS-CP-037 Product Surety
BMS-CP-039 Business Expenses
BMS-CP-040 Contracts and Similar Transactions
BMS-CP-043 Interactions with Healthcare Professionals
BMS-CP-044 Reporting Spontaneous Adverse Events for BMS Products
BMS-CP-048 Political Contributions
BMS-CP-049 Scientific Publications
BMS-CP-058 Disclosure of Federal Lobbying Activities
BMS-CP-063 Disclosure of Status as Ineligible Person
BMS-CP-064 Sanctioned Countries, Restricted Parties and Anti-boycott
BMS-CP-069 Human Rights

Our Compliance and Ethics Code of Conduct for U.S. Pharmaceuticals
(PDF: 219 KB)

Our Sharps Management Plan (PDF: 177 KB)
(Bristol-Myers Squibb Company Sharps Management Plan for the Continental United States, Alaska and Hawaii)

Required State Declarations

Our Annual Declaration of Compliance for the State of California (PDF: 102 KB)

Our Description for the State of California of the Bristol-Myers Squibb Comprehensive Compliance Program (PDF: 111 KB)

Our California Transparency in Supply Chains Act Disclosure (PDF: 53 KB)

© 2015 Bristol-Myers Squibb Company Legal Notice   »   Privacy Policy   »  Trademarks